Lithotripsie extra-corporelle chez des patients atteints de coagulopathies acquises ou congénitales.

Translated title of the contribution: Extracorporeal lithotripsy in patients with acquired or congenital coagulopathies

E. Montanari, G. Zanetti, A. Guarneri, A. Trinchieri, M. Seveso, A. Federici

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Post ESWL haemorragic complications are frequent and most patients experience temporary haematuria and focal intrarenal bleeding or perirenal haematoma are detected by NMR or US imaging. By tradition coagulation troubles have been a contraindication for ESWL but literature describes cases of coagulopathic patients treated with ESWL. From January 1992 to July 1993, 4 of our patients with severe haemostatis troubles (severe haemophilia A in two cases, acquired deficit of coagulation factors and mild thrombocytopenia secondary to post-necrotic hepatitis in 1 case and Glanzmann's thrombasthenia in 1 case) underwent ESWL using Dornier HM3 mod. or MPL 9000. An extensive haematological and clinical evaluation pre and post-ESWL with an adequate haematological prophylaxis (transfusion of blood derivatives) has been performed depending on the coagulation disorder. In our patients we did not observe any haemorragic complication and we propose a reappraisal of the contraindications of ESWL in subjects with coagulation disorders: careful evaluation of haemorragic risk factors, by suitable correction measures and close clinical and instrumental monitoring, allows a reduction of the risk of haemorragic complications in coagulopathic patients who undergo ESWL treatment.

Original languageFrench
Pages (from-to)706-710
Number of pages5
JournalProgres en Urologie
Volume5
Issue number5
Publication statusPublished - Nov 1995

Fingerprint

Lithotripsy
Thrombasthenia
Blood Coagulation Factors
Hemophilia A
Hematuria
Risk Reduction Behavior
Blood Transfusion
Thrombocytopenia
Hematoma
Hepatitis
Hemorrhage

Cite this

Montanari, E., Zanetti, G., Guarneri, A., Trinchieri, A., Seveso, M., & Federici, A. (1995). Lithotripsie extra-corporelle chez des patients atteints de coagulopathies acquises ou congénitales. Progres en Urologie, 5(5), 706-710.

Lithotripsie extra-corporelle chez des patients atteints de coagulopathies acquises ou congénitales. / Montanari, E.; Zanetti, G.; Guarneri, A.; Trinchieri, A.; Seveso, M.; Federici, A.

In: Progres en Urologie, Vol. 5, No. 5, 11.1995, p. 706-710.

Research output: Contribution to journalArticle

Montanari, E, Zanetti, G, Guarneri, A, Trinchieri, A, Seveso, M & Federici, A 1995, 'Lithotripsie extra-corporelle chez des patients atteints de coagulopathies acquises ou congénitales.', Progres en Urologie, vol. 5, no. 5, pp. 706-710.
Montanari E, Zanetti G, Guarneri A, Trinchieri A, Seveso M, Federici A. Lithotripsie extra-corporelle chez des patients atteints de coagulopathies acquises ou congénitales. Progres en Urologie. 1995 Nov;5(5):706-710.
Montanari, E. ; Zanetti, G. ; Guarneri, A. ; Trinchieri, A. ; Seveso, M. ; Federici, A. / Lithotripsie extra-corporelle chez des patients atteints de coagulopathies acquises ou congénitales. In: Progres en Urologie. 1995 ; Vol. 5, No. 5. pp. 706-710.
@article{26a7b75228f645e7ae9ffe5e5703d79b,
title = "Lithotripsie extra-corporelle chez des patients atteints de coagulopathies acquises ou cong{\'e}nitales.",
abstract = "Post ESWL haemorragic complications are frequent and most patients experience temporary haematuria and focal intrarenal bleeding or perirenal haematoma are detected by NMR or US imaging. By tradition coagulation troubles have been a contraindication for ESWL but literature describes cases of coagulopathic patients treated with ESWL. From January 1992 to July 1993, 4 of our patients with severe haemostatis troubles (severe haemophilia A in two cases, acquired deficit of coagulation factors and mild thrombocytopenia secondary to post-necrotic hepatitis in 1 case and Glanzmann's thrombasthenia in 1 case) underwent ESWL using Dornier HM3 mod. or MPL 9000. An extensive haematological and clinical evaluation pre and post-ESWL with an adequate haematological prophylaxis (transfusion of blood derivatives) has been performed depending on the coagulation disorder. In our patients we did not observe any haemorragic complication and we propose a reappraisal of the contraindications of ESWL in subjects with coagulation disorders: careful evaluation of haemorragic risk factors, by suitable correction measures and close clinical and instrumental monitoring, allows a reduction of the risk of haemorragic complications in coagulopathic patients who undergo ESWL treatment.",
author = "E. Montanari and G. Zanetti and A. Guarneri and A. Trinchieri and M. Seveso and A. Federici",
year = "1995",
month = "11",
language = "Francese",
volume = "5",
pages = "706--710",
journal = "Progres en Urologie",
issn = "1166-7087",
publisher = "Elsevier Masson",
number = "5",

}

TY - JOUR

T1 - Lithotripsie extra-corporelle chez des patients atteints de coagulopathies acquises ou congénitales.

AU - Montanari, E.

AU - Zanetti, G.

AU - Guarneri, A.

AU - Trinchieri, A.

AU - Seveso, M.

AU - Federici, A.

PY - 1995/11

Y1 - 1995/11

N2 - Post ESWL haemorragic complications are frequent and most patients experience temporary haematuria and focal intrarenal bleeding or perirenal haematoma are detected by NMR or US imaging. By tradition coagulation troubles have been a contraindication for ESWL but literature describes cases of coagulopathic patients treated with ESWL. From January 1992 to July 1993, 4 of our patients with severe haemostatis troubles (severe haemophilia A in two cases, acquired deficit of coagulation factors and mild thrombocytopenia secondary to post-necrotic hepatitis in 1 case and Glanzmann's thrombasthenia in 1 case) underwent ESWL using Dornier HM3 mod. or MPL 9000. An extensive haematological and clinical evaluation pre and post-ESWL with an adequate haematological prophylaxis (transfusion of blood derivatives) has been performed depending on the coagulation disorder. In our patients we did not observe any haemorragic complication and we propose a reappraisal of the contraindications of ESWL in subjects with coagulation disorders: careful evaluation of haemorragic risk factors, by suitable correction measures and close clinical and instrumental monitoring, allows a reduction of the risk of haemorragic complications in coagulopathic patients who undergo ESWL treatment.

AB - Post ESWL haemorragic complications are frequent and most patients experience temporary haematuria and focal intrarenal bleeding or perirenal haematoma are detected by NMR or US imaging. By tradition coagulation troubles have been a contraindication for ESWL but literature describes cases of coagulopathic patients treated with ESWL. From January 1992 to July 1993, 4 of our patients with severe haemostatis troubles (severe haemophilia A in two cases, acquired deficit of coagulation factors and mild thrombocytopenia secondary to post-necrotic hepatitis in 1 case and Glanzmann's thrombasthenia in 1 case) underwent ESWL using Dornier HM3 mod. or MPL 9000. An extensive haematological and clinical evaluation pre and post-ESWL with an adequate haematological prophylaxis (transfusion of blood derivatives) has been performed depending on the coagulation disorder. In our patients we did not observe any haemorragic complication and we propose a reappraisal of the contraindications of ESWL in subjects with coagulation disorders: careful evaluation of haemorragic risk factors, by suitable correction measures and close clinical and instrumental monitoring, allows a reduction of the risk of haemorragic complications in coagulopathic patients who undergo ESWL treatment.

UR - http://www.scopus.com/inward/record.url?scp=0029396710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029396710&partnerID=8YFLogxK

M3 - Articolo

VL - 5

SP - 706

EP - 710

JO - Progres en Urologie

JF - Progres en Urologie

SN - 1166-7087

IS - 5

ER -